Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Is it time to sell Antibe Therapeutics to Big Pharma?
View:
Post by mstrmnd on Aug 03, 2021 4:16pm

Is it time to sell Antibe Therapeutics to Big Pharma?

?
Comment by 123ABC on Aug 03, 2021 4:21pm
I think anyone would take a 1b buyout right now
Comment by fox7mf on Aug 03, 2021 4:33pm
Yup...and I'd sell for $1b cad in a sec.
Comment by topadvisor1 on Aug 03, 2021 4:46pm
This post has been removed in accordance with Community Policy
Comment by raven16 on Aug 03, 2021 5:01pm
Hi topadvisor1 - Just Wondering If You Have Shares In ATE?
Comment by mstrmnd on Aug 03, 2021 5:25pm
Well wouldn't it be the perfect way to sabotage an NSAID industry-wide competitor to force accepting a low-ball offer? Don't be stupid, 5 years later, we know a lot more about liver enzyme elevation in ATB-346 (Otenaproxesul) than in 2015 including at 250 mg, 200 mg, 150 mg, 100 mg, and 75 mg 5x upper limit of normal for liver enzymes, is actually NOT that high, it's just the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities